Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.13 and traded as high as $0.13. Enzon Pharmaceuticals shares last traded at $0.11, with a volume of 2,191 shares trading hands.
Enzon Pharmaceuticals Stock Performance
The stock has a market cap of $8.16 million, a price-to-earnings ratio of 11.00 and a beta of 0.48. The business’s fifty day simple moving average is $0.14 and its 200 day simple moving average is $0.13.
Enzon Pharmaceuticals Company Profile
Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.
Read More
- Five stocks we like better than Enzon Pharmaceuticals
- Low PE Growth Stocks: Unlocking Investment Opportunities
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- Using the MarketBeat Dividend Tax Calculator
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- Compound Interest and Why It Matters When Investing
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.